Skip to main content
Erschienen in: Cancer Causes & Control 7/2012

01.07.2012 | Original Paper

Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study

verfasst von: Jacqueline M. Major, M. Norman Oliver, Chyke A. Doubeni, Albert R. Hollenbeck, Barry I. Graubard, Rashmi Sinha

Erschienen in: Cancer Causes & Control | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The purpose of this study was to separately examine the impact of neighborhood socioeconomic deprivation and availability of healthcare resources on prostate cancer risk among African American and Caucasian men.

Methods

In the large, prospective NIH-AARP Diet and Health Study, we analyzed baseline (1995–1996) data from adult men, aged 50–71 years. Incident prostate cancer cases (n = 22,523; 1,089 among African Americans) were identified through December 2006. Lifestyle and health risk information was ascertained by questionnaires administered at baseline. Area-level socioeconomic indicators were ascertained by linkage to the US Census and the Area Resource File. Multilevel Cox models were used to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs).

Results

A differential effect among African Americans and Caucasians was observed for neighborhood deprivation (p-interaction = 0.04), percent uninsured (p-interaction = 0.02), and urologist density (p-interaction = 0.01). Compared to men living in counties with the highest density of urologists, those with fewer had a substantially increased risk of developing advanced prostate cancer (HR = 2.68, 95 % CI = 1.31, 5.47) among African American.

Conclusions

Certain socioeconomic indicators were associated with an increased risk of prostate cancer among African American men compared to Caucasians. Minimizing differences in healthcare availability may be a potentially important pathway to minimizing disparities in prostate cancer risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300 Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300
2.
Zurück zum Zitat Brawley OW, Jani AB, Master V (2007) Prostate cancer and race. Curr Probl Cancer 31:211–225 Brawley OW, Jani AB, Master V (2007) Prostate cancer and race. Curr Probl Cancer 31:211–225
3.
Zurück zum Zitat The Unequal Burden of Cancer (1999) An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. National Academy of Sciences, Washington, DC The Unequal Burden of Cancer (1999) An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. National Academy of Sciences, Washington, DC
4.
Zurück zum Zitat Devesa S, Grauman D, Blot W, Pennello G, Hoover R, Fraumeni J (1999) Atlas of cancer mortality in the United States, 1950–94. National Institutes of Health, National Cancer Institute, Bethesda Devesa S, Grauman D, Blot W, Pennello G, Hoover R, Fraumeni J (1999) Atlas of cancer mortality in the United States, 1950–94. National Institutes of Health, National Cancer Institute, Bethesda
5.
Zurück zum Zitat Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS et al (2009) Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology 73:620–623 Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS et al (2009) Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology 73:620–623
6.
Zurück zum Zitat Robbins AS, Yin D, Parikh-Patel A (2007) Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004. Am J Epidemiol 166:71–78 Robbins AS, Yin D, Parikh-Patel A (2007) Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004. Am J Epidemiol 166:71–78
7.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W et al (2010) SEER Cancer Statistics Review, 1975–2008. National Cancer Institute, Bethesda Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W et al (2010) SEER Cancer Statistics Review, 1975–2008. National Cancer Institute, Bethesda
8.
Zurück zum Zitat Gilligan T (2005) Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control 16(1):45–53PubMedCrossRef Gilligan T (2005) Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control 16(1):45–53PubMedCrossRef
9.
Zurück zum Zitat Satia JA, Galanko JA (2007) Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans. J Health Care Poor Underserved 18(4 Suppl):146–164PubMedCrossRef Satia JA, Galanko JA (2007) Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans. J Health Care Poor Underserved 18(4 Suppl):146–164PubMedCrossRef
10.
Zurück zum Zitat Jones NR, Williamson A, Foote M, Creswell PD, Strickland R, Remington P et al (2010) Cancer health disparities persist among African Americans in Wisconsin. WMJ 109(5):267–273PubMed Jones NR, Williamson A, Foote M, Creswell PD, Strickland R, Remington P et al (2010) Cancer health disparities persist among African Americans in Wisconsin. WMJ 109(5):267–273PubMed
11.
Zurück zum Zitat Oliver MN, Smith E, Siadaty M, Hauck FR, Pickle LW (2006) Spatial analysis of prostate cancer incidence and race in Virginia, 1990–1999. Am J Prev Med 30:S67–76 Oliver MN, Smith E, Siadaty M, Hauck FR, Pickle LW (2006) Spatial analysis of prostate cancer incidence and race in Virginia, 1990–1999. Am J Prev Med 30:S67–76
12.
Zurück zum Zitat Blankart CR (2012) Does healthcare infrastructure have an impact on delay in diagnosis and survival? Health Policy 105(2–3):128–137PubMedCrossRef Blankart CR (2012) Does healthcare infrastructure have an impact on delay in diagnosis and survival? Health Policy 105(2–3):128–137PubMedCrossRef
13.
Zurück zum Zitat Ananthakrishnan AN, Hoffmann RG, Saeian K (2010) Higher physician density is associated with lower incidence of late-stage colorectal cancer. J Gen Intern Med 25(11):1164–1171PubMedCrossRef Ananthakrishnan AN, Hoffmann RG, Saeian K (2010) Higher physician density is associated with lower incidence of late-stage colorectal cancer. J Gen Intern Med 25(11):1164–1171PubMedCrossRef
14.
Zurück zum Zitat Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR et al (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154(12):1119–1125PubMedCrossRef Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR et al (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154(12):1119–1125PubMedCrossRef
15.
Zurück zum Zitat Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New YorkCrossRef Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New YorkCrossRef
16.
Zurück zum Zitat Michaud D, Midthune D, Hermansen S, Leitzmann M, Harlan L, Kipnis V et al (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Regist Manag 32:70–77 Michaud D, Midthune D, Hermansen S, Leitzmann M, Harlan L, Kipnis V et al (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Regist Manag 32:70–77
17.
Zurück zum Zitat American Joint Committee on Cancer (1997) Manual for staging of cancer, 5th edn. Lippincott-Raven, Philadelphia American Joint Committee on Cancer (1997) Manual for staging of cancer, 5th edn. Lippincott-Raven, Philadelphia
18.
Zurück zum Zitat Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4 Suppl):1220S–1228S (discussion 1229S-1231S) Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4 Suppl):1220S–1228S (discussion 1229S-1231S)
19.
Zurück zum Zitat Major JM, Doubeni CA, Freedman ND, Park Y, Lian M, Hollenbeck AR et al (2010) Neighborhood socioeconomic deprivation and mortality: NIH-AARP diet and health study. PLoS One 5(11):e15538PubMedCrossRef Major JM, Doubeni CA, Freedman ND, Park Y, Lian M, Hollenbeck AR et al (2010) Neighborhood socioeconomic deprivation and mortality: NIH-AARP diet and health study. PLoS One 5(11):e15538PubMedCrossRef
20.
Zurück zum Zitat Messer LC, Laraia BA, Kaufman JS, Eyster J, Holzman C, Culhane J et al (2006) The development of a standardized neighborhood deprivation index. J Urban Health 83(6):1041–1062PubMedCrossRef Messer LC, Laraia BA, Kaufman JS, Eyster J, Holzman C, Culhane J et al (2006) The development of a standardized neighborhood deprivation index. J Urban Health 83(6):1041–1062PubMedCrossRef
21.
Zurück zum Zitat Fedewa SA, Etzioni R, Flanders WD, Jemal A, Ward EM (2010) Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004–2006. Cancer Epidemiol Biomarkers Prev 19:2437–2444 Fedewa SA, Etzioni R, Flanders WD, Jemal A, Ward EM (2010) Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004–2006. Cancer Epidemiol Biomarkers Prev 19:2437–2444
22.
Zurück zum Zitat Zeigler-Johnson CM, Tierney A, Rebbeck TR, Rundle A (2011) Prostate cancer severity associations with neighborhood deprivation. Prostate Cancer 2011:846263PubMedCrossRef Zeigler-Johnson CM, Tierney A, Rebbeck TR, Rundle A (2011) Prostate cancer severity associations with neighborhood deprivation. Prostate Cancer 2011:846263PubMedCrossRef
23.
Zurück zum Zitat Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR (2009) Geographic distribution of urologists throughout the United States using a county level approach. J Urol 181:760–765 (discussion 765–766) Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR (2009) Geographic distribution of urologists throughout the United States using a county level approach. J Urol 181:760–765 (discussion 765–766)
24.
Zurück zum Zitat Holmes JA, Carpenter WR, Wu Y, Hendrix LH, Peacock S, Massing M et al (2012) Impact of Distance to a Urologist on Early Diagnosis of Prostate Cancer Among Black and White Patients. J Urol 187(3):883–888 Holmes JA, Carpenter WR, Wu Y, Hendrix LH, Peacock S, Massing M et al (2012) Impact of Distance to a Urologist on Early Diagnosis of Prostate Cancer Among Black and White Patients. J Urol 187(3):883–888
25.
Zurück zum Zitat Patel K, Kenerson D, Wang H, Brown B, Pinkerton H, Burress M et al (2010) Factors influencing prostate cancer screening in low-income African Americans in Tennessee. J Health Care Poor Underserved 21(1 Suppl):114–126PubMedCrossRef Patel K, Kenerson D, Wang H, Brown B, Pinkerton H, Burress M et al (2010) Factors influencing prostate cancer screening in low-income African Americans in Tennessee. J Health Care Poor Underserved 21(1 Suppl):114–126PubMedCrossRef
26.
Zurück zum Zitat Colli JL, Amling CL (2008) Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America. Prostate Cancer Prostatic Dis 11(3):247–251PubMedCrossRef Colli JL, Amling CL (2008) Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America. Prostate Cancer Prostatic Dis 11(3):247–251PubMedCrossRef
27.
Zurück zum Zitat Woods VD, Montgomery SB, Herring RP, Gardner RW, Stokols D (2006) Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men. J Natl Med Assoc 98(4):492–504PubMed Woods VD, Montgomery SB, Herring RP, Gardner RW, Stokols D (2006) Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men. J Natl Med Assoc 98(4):492–504PubMed
Metadaten
Titel
Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study
verfasst von
Jacqueline M. Major
M. Norman Oliver
Chyke A. Doubeni
Albert R. Hollenbeck
Barry I. Graubard
Rashmi Sinha
Publikationsdatum
01.07.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 7/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9988-8

Weitere Artikel der Ausgabe 7/2012

Cancer Causes & Control 7/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.